MX2011007414A - Composicion farmaceutica para proteger a un animal contra un trastorno que se origina de una infeccion con una bacteria que pertenece al grupo de actinomicentos nacardioformes. - Google Patents

Composicion farmaceutica para proteger a un animal contra un trastorno que se origina de una infeccion con una bacteria que pertenece al grupo de actinomicentos nacardioformes.

Info

Publication number
MX2011007414A
MX2011007414A MX2011007414A MX2011007414A MX2011007414A MX 2011007414 A MX2011007414 A MX 2011007414A MX 2011007414 A MX2011007414 A MX 2011007414A MX 2011007414 A MX2011007414 A MX 2011007414A MX 2011007414 A MX2011007414 A MX 2011007414A
Authority
MX
Mexico
Prior art keywords
bacterium
infection
protect
belongs
pharmaceutical composition
Prior art date
Application number
MX2011007414A
Other languages
English (en)
Inventor
Antonius Arnoldus Christiaan Jacobs
Robert Van Der Geize
Lubbert Dijkhuizen
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of MX2011007414A publication Critical patent/MX2011007414A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La invención pertenece a una composición farmacéutica para proteger un animal contra un trastorno que se origina de una infección con una bacteria que pertenece al grupo de actinomicetos nacardioformes que tienen la capacidad de sobrevivir dentro de los macrófagos del animal, que comprende bacterias vivas de una especie de actinomicetos nacardioformes, las bacterias vivas son atenuadas por la inactivación de un gen que codifica una proteína implicada en la degradación del propionato de metilhexahidroindandiona, y un portador farmacéuticamente aceptable para estas bacterias vivas.
MX2011007414A 2009-01-12 2010-01-11 Composicion farmaceutica para proteger a un animal contra un trastorno que se origina de una infeccion con una bacteria que pertenece al grupo de actinomicentos nacardioformes. MX2011007414A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14386909P 2009-01-12 2009-01-12
EP09150379 2009-01-12
PCT/EP2010/050196 WO2010079224A1 (en) 2009-01-12 2010-01-11 Pharmaceutical composition to protect an animal against a disorder arising from an infection with a bacterium that belongs to the group of nocardioform actinomycetes

Publications (1)

Publication Number Publication Date
MX2011007414A true MX2011007414A (es) 2012-03-16

Family

ID=40756390

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011007414A MX2011007414A (es) 2009-01-12 2010-01-11 Composicion farmaceutica para proteger a un animal contra un trastorno que se origina de una infeccion con una bacteria que pertenece al grupo de actinomicentos nacardioformes.

Country Status (14)

Country Link
US (1) US8574565B2 (es)
EP (1) EP2385836B1 (es)
JP (1) JP5540325B2 (es)
CN (1) CN102271693B (es)
AR (1) AR075013A1 (es)
AU (1) AU2010204269B2 (es)
BR (1) BRPI1006875B8 (es)
CA (1) CA2749075C (es)
MX (1) MX2011007414A (es)
NZ (1) NZ593588A (es)
RU (1) RU2543663C2 (es)
TW (1) TWI458489B (es)
WO (1) WO2010079224A1 (es)
ZA (1) ZA201104714B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2785607A1 (en) * 2010-01-04 2011-07-07 Intervet International B.V. Administration route for a composition to protect an animal against rhodococcus equi
WO2015191744A1 (en) * 2014-06-10 2015-12-17 Georgia State University And Research Foundation, Inc. Inhibiting or reducing fungal infections
CN104232535B (zh) * 2014-09-02 2017-04-26 广东海洋大学 鰤鱼诺卡氏菌诱变弱毒株及其应用
CN105622422B (zh) * 2016-01-29 2017-12-05 南开大学 一类溴代六氢茚酮类化合物及其制备方法和用途
WO2020145663A1 (ko) * 2019-01-09 2020-07-16 주식회사 엠디헬스케어 로도코커스 속 세균 유래 나노소포 및 이의 용도
CN112939860B (zh) * 2019-11-11 2022-11-11 山东畜牧兽医职业学院 一种治疗耐药性革兰阴阳性菌的化合物及其制备方法
CN112746050B (zh) * 2020-12-22 2021-12-24 广东海洋大学深圳研究院 一种鰤鱼诺卡氏菌减毒株及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721242A (en) * 1993-06-17 1998-02-24 Hoffmann-La Roche Inc. Antibiotic combination
AU8604698A (en) * 1997-07-28 1999-02-16 Temple University - Of The Commonwealth System Of Higher Education Genetically engineered rhodococcus vaccine
NZ538163A (en) * 2002-07-16 2008-04-30 Harvard College Rhodococcus equi mutants and vaccines comprising same
US8481530B2 (en) * 2006-12-01 2013-07-09 The Research Foundation Of State University Of New York 3β-hydroxysteroid dehydrogenase inhibitors
WO2009024572A1 (en) * 2007-08-21 2009-02-26 N.V. Organon Method for the production of modified steroid degrading microorganisms and their use

Also Published As

Publication number Publication date
WO2010079224A1 (en) 2010-07-15
ZA201104714B (en) 2012-03-28
CN102271693B (zh) 2013-11-06
CA2749075A1 (en) 2010-07-15
BRPI1006875B8 (pt) 2021-05-25
JP2012515147A (ja) 2012-07-05
US8574565B2 (en) 2013-11-05
AU2010204269A1 (en) 2011-08-04
CN102271693A (zh) 2011-12-07
AR075013A1 (es) 2011-03-02
US20110274660A1 (en) 2011-11-10
CA2749075C (en) 2017-02-21
NZ593588A (en) 2012-12-21
EP2385836A1 (en) 2011-11-16
JP5540325B2 (ja) 2014-07-02
EP2385836B1 (en) 2016-05-25
BRPI1006875A2 (pt) 2016-08-09
AU2010204269B2 (en) 2015-05-07
TWI458489B (zh) 2014-11-01
TW201036631A (en) 2010-10-16
RU2543663C2 (ru) 2015-03-10
RU2011133824A (ru) 2013-02-20
BRPI1006875B1 (pt) 2020-10-20

Similar Documents

Publication Publication Date Title
MX2011007414A (es) Composicion farmaceutica para proteger a un animal contra un trastorno que se origina de una infeccion con una bacteria que pertenece al grupo de actinomicentos nacardioformes.
PH12016502092A1 (en) Antimicrobial compounds and methods of making and using the same
EP2494059A4 (en) USE OF METHYSULFONYLMETHANE (MSM) FOR MODULATION OF MICROBIAL ACTIVITY
MY176900A (en) Antimicrobial compounds and methods of making and using the same
UA110199C2 (en) Solid rifaximin dispersion
MX2017008561A (es) Novedoso bacteriófago clo-pep-1 de clostridium perfringens y su uso para inhibir la proliferación de clostridium perfringens.
MX351670B (es) Bacteria bacillus para uso en tratar y prevenir infecciones en animales acuaticos.
EP2373693A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF ORAL INFECTIONS BY E. COLI
GB2480772A (en) Compositions and methods for the treatment or prevention of staphylococcus aureus infections and for the eradication or reduction of staphylococcus aureus
WO2018208987A3 (en) Antibacterial compounds
EA201000383A1 (ru) Способ ингибирования клостридиум диффициле введением оритаванцина
PH12015502375B1 (en) Antimicrobial compounds and methods of making and using the same
MX2021003084A (es) Compuestos antibacterianos.
EP2588121A4 (en) C5A ANALOGUES AND METHODS OF USE THEREOF
MX2015015506A (es) Peptidos antimicrobianos.
MX2011008043A (es) Derivados de actagardina.
NZ596628A (en) Ketolide compounds having antimicrobial activity
MX2012000136A (es) Composiciones que comprenden finafloxacina y metodos para tratar infecciones oftalmicas, oticas, o nasales.
MY161870A (en) Antimicrobial compounds and methods of making and using the same
AU2011365688A8 (en) Peptides with antimicrobial activity, drug compositions for the prophylaxis and treatment of animals, compositions for the prophylaxis and treatment of plants, uses of said peptides, and uses of Paenibacillus elgii ourofinensis extract
CL2013000331A1 (es) Compuestos derivados de triazina-1,2 diazol condezada o de triazina-1,2,4-triazol condensada; proceso para preparar estos compuestos; composicion farmaceutica; proceso para preparar esta composicion farmaceutica; y su uso para el tratamiento de una infeccion bacteriana tal como una infeccion por la bacteria clostridium.
WO2018117462A3 (ko) 신규한 비브리오 파라헤몰리티쿠스 박테리오파지 Ｖｉｂ-ＰＡＰ-4 및 이의 비브리오 파라헤몰리티쿠스 균 증식 억제 용도
MX360559B (es) Péptidos antimicrobianos, composiciones que los comprende y usos.
IL299751A (en) Preparations and methods for disinfection, treatment and prevention of bacterial infections
MX337145B (es) Composiciones farmaceuticas.

Legal Events

Date Code Title Description
FG Grant or registration